Paper Review Records
All Paper Review Records
13 valid samples · Newest publication first
Review days = acceptance date − received date. PDF, DOI, and publisher-page sources are retained.
Management of high-risk non-muscle invasive bladder cancer: a real-world study in North America, Europe and Japan
AuthorsJens Bedke; Anthony Eccleston; Mia Unsworth; Julia Brinkmann; Jane Chang; Abin Koshy; Laure Manuel; Jacob Skilling; Emilia Biondi; Elliott Brown; Caitlin Ford; Gary Steinberg; Yair Lotan; Yohann Loriot; Oscar Rodriguez Faba
Affiliations1. Eva Mayr-Stihl Cancer Center, Klinikum Stuttgart; 2. Pfizer Inc; 3. Adelphi Real World; 4. Pfizer; 5. Rush University; 6. University of Texas Southwestern Medical Center; 7. Gustave Roussy; 8. Fundació Puigvert, Autonomous University of Barcelona
Efficacy analysis of first-line chemoimmunotherapy with or without radiotherapy in stage IVB esophageal squamous cell carcinoma: a real-world study
AuthorsYanhui Zhang; Yuqin Jin; Ruidan Zhang; Junfeng Zhao; Baosheng Li
Affiliations1. Shandong First Medical University and Shandong Academy of Medical Sciences
TANGENT study design: a phase III, randomized study of emactuzumab for the treatment of tenosynovial giant cell tumors
AuthorsHans Gelderblom; Emanuela Palmerini; Michiel van de Sande; Javier Martin-Broto; Gabriel Tinoco; Elyse Seltzer; Madhu Davies; Ruth Coll; Sander Veltkamp; Jean-Yves Blay
Affiliations1. Leiden University Medical Center; 2. IRCCS Istituto Ortopedico Rizzoli; 3. Leiden University Medical Centre; 4. Fundación Jimenez Diaz University Hospital; 5. University Hospital General de Villalba; 6. Instituto de Investigacion Sanitaria Fundacion Jimenez Diaz (IIS/FJD; UAM); 7. The Ohio State University Comprehensive Cancer Center; 8. Clinical Development, SynOx Therapeutics Inc., Philadelphia, PA, USA; 9. Clinical Development, SynOx Therapeutics Ltd., Oxford, UK; 10. Centre Léon Bérard
Expert Matching · Case Demo
Turn Your Submission Goalsinto a Verifiable Journal Plan
Share your field, deadline, and author profile. CrushSCI uses real review records to suggest a title direction, shortlist journals, and estimate timelines.
